Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Animal Blood & Blood Components Market Size & Growth Forecast 2027–2036, By Segments (Product, Animal Type, End-user, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 8247| Published Date: Sep-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Animal Blood & Blood Components Market size was valued at USD 168.04 Million in 2026 and is anticipated to grow at 10.28% CAGR from 2027 to 2036, exceeding USD 447.07 Million by 2036. The industry revenue for 2027 is estimated at USD 182.71 Million.

Base Year Value (2026)
USD 168.04 Million
CAGR (2027-2036)
10.28%
Forecast Year Value (2036)
USD 447.07 Million
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

Animal Blood & Blood Components Market Intelligence Snapshot

Regional Market Dynamics

  • North America held 52.26% in 2026, supported by advanced veterinary infrastructure, established animal healthcare practices, and demand for specialized transfusion and treatment services.
  • Asia Pacific is expected to grow fastest as livestock production, companion animal ownership, veterinary infrastructure, and investments in animal healthcare expand.

Segment Momentum

  • Blood components held a 68.54% market share in 2026 because they support targeted therapies and diagnostics, offering greater flexibility and more efficient use of biological resources in veterinary care.
  • Small animals represent the fastest-growing segment, driven by expanding companion animal healthcare, increasing preventive care, and greater access to specialized veterinary services and emergency treatments.

Market Expansion Drivers

  • Rising companion animal ownership increasing demand for veterinary transfusion and blood banking services
  • Growing prevalence of chronic diseases in pets driving demand for advanced veterinary treatments
  • Advancements in blood typing and storage technologies improving veterinary transfusion success rates

Leading Market Participants

  • Prominent companies in the animal blood & blood components market include Animal Blood Resources International (United States), Blue Ridge Veterinary Blood Bank (United States), UC Davis Veterinary Medical Teaching Hospital (United States), Cornell University College of Veterinary Medicine (United States), University of Pennsylvania Ryan Veterinary Hospital (United States), University of Florida Veterinary Hospitals (United States), Royal Veterinary College (United Kingdom), University of Tokyo Veterinary Medical Center (Japan), Japan Animal Referral Medical Center (Japan), Hemopet (United States)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 168.04 Million
  • 2027 Estimated Market Size: USD 182.71 Million
  • Projected Market Size: USD 447.07 Million by 2036
  • Growth Forecast: 10.28% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Blood Components (Product) | Large Animals (Animal Type) | Veterinary Hospitals and Clinics (End-user) | Anemia (Application)
  • Emerging Opportunity Segment: Blood Components (Product) | Small Animals (Animal Type) | Veterinary Hospitals and Clinics (End-user) | Surgery (Application)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising companion animal ownership increasing demand for veterinary transfusion and blood banking services

The growing number of companion animals has expanded the need for specialized veterinary care, including emergency medicine, surgical procedures, and critical care services requiring blood transfusions. The animal blood & blood components market growth is driven by increasing demand for organized blood banking programs that ensure timely access to compatible blood products for dogs, cats, and other companion animals. Veterinary hospitals and specialty clinics are strengthening donor screening, collection, processing, and storage capabilities to support a broader range of transfusion therapies across routine and emergency clinical settings.

Growing prevalence of chronic diseases in pets driving demand for advanced veterinary treatments

Chronic health conditions in companion animals are increasing the complexity of veterinary treatment, creating greater reliance on supportive therapies that improve patient outcomes during prolonged medical care. As veterinarians manage disorders involving blood loss, immune dysfunction, cancer, and other systemic illnesses, the animal blood & blood components market will witness stronger demand for plasma, packed red blood cells, and other specialized blood products that complement advanced diagnostic and therapeutic procedures. The availability of these components enables more targeted treatment approaches tailored to different clinical conditions.

Advancements in blood typing and storage technologies improving veterinary transfusion success rates

Continuous improvements in veterinary transfusion medicine are enhancing the safety and effectiveness of blood product administration through more accurate compatibility testing and better preservation techniques. The animal blood & blood components market will benefit from innovations in blood typing, cross-matching, storage media, and inventory management that reduce transfusion-related complications while extending the usability of collected blood products. These technological developments support higher clinical confidence among veterinary professionals by improving product quality and facilitating faster access to suitable blood components for diverse treatment requirements.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising companion animal ownership increasing demand for veterinary transfusion and blood banking services 3.1% High North America, Europe High Near Term
Growing prevalence of chronic diseases in pets driving demand for advanced veterinary treatments 2.8% High North America, Asia Pacific High Near Term
Advancements in blood typing and storage technologies improving veterinary transfusion success rates 2.3% High Europe, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
52.26% Market Share in 2026

North America (Largest Region)

North America held the largest share of 52.26% in the animal blood & blood components market in 2026, supported by advanced veterinary healthcare infrastructure, well-established animal healthcare practices, and increasing demand for specialized veterinary treatments. The region's developed livestock and companion animal sectors create sustained requirements for blood and blood-derived products used in transfusion procedures, emergency care, surgery, and disease management. Strong veterinary diagnostic capabilities, improved access to specialized clinical services, and greater awareness of animal health are also supporting the adoption of blood components and strengthening the regional market.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is expected to register the fastest growth, driven by expanding livestock production, rising companion animal ownership, and improving veterinary healthcare infrastructure. Increasing awareness of animal disease prevention and treatment is encouraging greater use of advanced veterinary procedures, including transfusion-based care. The expansion of veterinary hospitals and diagnostic facilities, coupled with growing investments in animal healthcare and increasing demand for healthier livestock, is creating favorable conditions for broader utilization of animal blood and blood components across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Integrated Processing Standards

The U.S. animal blood & blood components market benefits from established meat processing infrastructure and growing demand for pharmaceutical, feed, and research applications. Companies prioritize traceability, quality assurance, and efficient collection systems to maximize raw material utilization.

Germany 🇩🇪

Regulated Ingredient Quality

Germany emphasizes high-quality animal blood processing supported by strict manufacturing and safety requirements. Producers focus on specialized blood components for biotechnology, diagnostics, and animal nutrition while maintaining consistent regulatory compliance.

Japan 🇯🇵

High-Purity Bioprocessing

Japan concentrates on refined animal blood components for pharmaceutical research, diagnostics, and specialty industrial applications. Companies invest in advanced processing technologies that improve purity, product consistency, and application-specific performance.

South Korea 🇰🇷

Biotech Supply Expansion

South Korea is expanding processing capabilities for animal blood components to support biotechnology, research, and animal nutrition industries. Market participants strengthen quality control and processing efficiency to satisfy both domestic and export requirements.

France 🇫🇷

Value-Added Byproduct Use

France encourages efficient utilization of animal blood through value-added processing for feed, pharmaceutical, and industrial applications. Companies focus on sustainable resource management while meeting strict product quality and traceability expectations.

Italy 🇮🇹

Specialty Processing Expertise

Italy supports the animal blood & blood components market through specialized processing for animal nutrition, pharmaceutical, and technical applications. Producers emphasize consistent raw material handling and product differentiation to address diverse customer requirements.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Blood Components (Largest & Fastest-Growing Segment)

The blood components segment dominated the animal blood & blood components market, accounting for the largest share of 68.54% in 2026 while also emerging as the fastest-growing product segment. The segment’s strong position is driven by the increasing preference for targeted blood-based therapies and diagnostic applications that utilize specific components rather than whole blood. Blood components provide greater flexibility in veterinary treatments by enabling the use of specialized elements for different medical requirements. Growing demand for advanced veterinary care, improved animal health management, and efficient utilization of biological resources is supporting the expansion of this segment.

Animal Type Segment Analysis: Large Animals (Largest Segment) vs Small Animals (Fastest-Growing Segment)

In the animal blood & blood components market, the large animals segment captured the largest share of 60.63% in 2026. This segment benefits from the importance of blood-based medical interventions in livestock and other large animal populations, where maintaining animal health is essential for productivity and disease management. The demand for veterinary diagnostics, transfusion support, and healthcare solutions for large animals continues to strengthen the segment’s market presence.

The small animals segment is expected to register the fastest growth as veterinary healthcare for companion animals continues to become more advanced and accessible. Increasing attention toward preventive care, emergency treatments, and specialized veterinary services is creating greater demand for blood products for small animals. The growing focus on companion animal health and improved availability of veterinary facilities is contributing to the rising adoption of blood components in this segment.

End-user Segment Analysis: Veterinary Hospitals and Clinics (Largest & Fastest-Growing Segment)

The veterinary hospitals and clinics segment led the animal blood & blood components market and represented both the largest and fastest-growing end-user segment in 2026. These facilities serve as primary points of care for animal diagnostics, treatment, and transfusion-related procedures, driving consistent demand for blood products. Their ability to provide specialized veterinary services and manage complex health conditions supports continued adoption of animal blood components. Increasing investment in veterinary healthcare infrastructure and the growing need for professional animal care services are further strengthening this segment.

Segment Sub-Segment Largest Segment Fastest Growing
Product Blood Components, Whole Blood Blood Components Blood Components
Animal Type Large Animals, Small Animals Large Animals Small Animals
End-user Veterinary Hospitals and Clinics, Veterinary Blood Banks Veterinary Hospitals and Clinics Veterinary Hospitals and Clinics
Application Anemia, Surgery, Bleeding Disorders, Others Anemia Surgery
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the animal blood & blood components market:

  1. Animal Blood Resources International (United States)
  2. Blue Ridge Veterinary Blood Bank (United States)
  3. UC Davis Veterinary Medical Teaching Hospital (United States)
  4. Cornell University College of Veterinary Medicine (United States)
  5. University of Pennsylvania Ryan Veterinary Hospital (United States)
  6. University of Florida Veterinary Hospitals (United States)
  7. Royal Veterinary College (United Kingdom)
  8. University of Tokyo Veterinary Medical Center (Japan)
  9. Japan Animal Referral Medical Center (Japan)
  10. Hemopet (United States)

Competitive priorities are shifting toward suppliers that can deliver consistent biological quality, traceable sourcing, and processing capabilities aligned with increasingly specialized end-use requirements. As demand expands across pharmaceutical, diagnostic, research, and biotechnology applications, differentiation is relying less on raw material availability and more on purification expertise, quality assurance systems, and regulatory compliance throughout the production chain. Entry barriers are also rising as customers favor partners capable of maintaining reliable supply continuity and validated manufacturing processes, encouraging investment in integrated collection, processing, and storage infrastructure rather than standalone production capacity.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Animal Blood Resources International (United States)
Blue Ridge Veterinary Blood Bank (United States)
UC Davis Veterinary Medical Teaching Hospital (United States)
Cornell University College of Veterinary Medicine (United States)
University of Pennsylvania Ryan Veterinary Hospital (United States)
University of Florida Veterinary Hospitals (United States)
Royal Veterinary College (United Kingdom)
University of Tokyo Veterinary Medical Center (Japan)
Japan Animal Referral Medical Center (Japan)
Hemopet (United States)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Animal Blood & Blood Components Market — Custom Segments

Segment Sub-Segment
Donor Source Voluntary Donor Programs, Animal Blood Banks, Commercial Donor Programs, Hospital-Managed Donors
Procurement Model Direct Procurement, Veterinary Blood Bank Procurement, Distributor-Mediated Procurement, Emergency Procurement
Blood Collection & Supply Model In-House Collection, Mobile Collection Programs, Centralized Blood Bank Supply, External Supplier Supply

Animal Blood & Blood Components Market — report.custom

Custom Chapter Custom Details
Veterinary Blood Banking Landscape
  • Blood Banking Models and Operating Structures
  • Veterinary Blood Collection and Storage Infrastructure
  • Regional Availability and Service Coverage
  • Institutional Models for Blood Bank Development
Clinical Demand Mapping
  • Demand Patterns Across Veterinary Care Settings
  • Blood Component Requirements by Clinical Application
  • Species-Specific Demand Characteristics
  • Emergency and Specialized Care Demand
  • Unmet Clinical Requirements and Service Gaps
Supply Resilience & Emergency Preparedness
  • Blood Supply Continuity and Critical Dependency Mapping
  • Donor Availability and Collection Capacity
  • Emergency Stock Management and Contingency Models
  • Regional Supply Disruptions and Response Mechanisms
  • Resilience Priorities for Veterinary Blood Services

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the animal blood & blood components market?

As of 2027 the market size of animal blood & blood components is valued at USD 182.71 Million.

What is the anticipated CAGR of the animal blood & blood components industry?

Animal Blood & Blood Components Market size was valued at USD 168.04 Million in 2026 and is anticipated to grow at 10.28% CAGR from 2027 to 2036, exceeding USD 447.07 Million by 2036.

How is rising companion animal ownership driving demand for veterinary blood products?

Growing pet ownership is increasing the need for veterinary transfusions, prompting hospitals and specialty clinics to expand blood banking, donor screening, processing, and storage capabilities for routine and emergency care.

How are technological advancements improving the animal blood and blood components market?

Innovations in blood typing, cross-matching, storage technologies, and inventory management are enhancing transfusion safety, extending product usability, and improving access to compatible blood products for veterinary treatment.

Why do blood components lead the animal blood & blood components market?

Blood components held a 68.54% market share in 2026 because they support targeted therapies and diagnostics, offering greater flexibility and more efficient use of biological resources in veterinary care.

Which animal type is growing the fastest in the animal blood & blood components market?

Small animals represent the fastest-growing segment, driven by expanding companion animal healthcare, increasing preventive care, and greater access to specialized veterinary services and emergency treatments.

What makes North America the leading animal blood and blood components market?

North America held 52.26% in 2026, supported by advanced veterinary infrastructure, established animal healthcare practices, and demand for specialized transfusion and treatment services.

Why is Asia Pacific expected to be the fastest-growing region?

Asia Pacific is expected to grow fastest as livestock production, companion animal ownership, veterinary infrastructure, and investments in animal healthcare expand.

Who are the major participants shaping the animal blood & blood components landscape?

Prominent companies in the animal blood & blood components market include Animal Blood Resources International (United States), Blue Ridge Veterinary Blood Bank (United States), UC Davis Veterinary Medical Teaching Hospital (United States), Cornell University College of Veterinary Medicine (United States), University of Pennsylvania Ryan Veterinary Hospital (United States), University of Florida Veterinary Hospitals (United States), Royal Veterinary College (United Kingdom), University of Tokyo Veterinary Medical Center (Japan), Japan Animal Referral Medical Center (Japan), Hemopet (United States)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →